MRI risk stratification for tumor relapse in rectal cancer achieving pathological complete remission after neoadjuvant chemoradiation therapy and curative resection

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Kim, Honsoul ^a   Myoung, Sungmin ^b   Koom, Woong Sub ^a   Kim, Nam Kyu ^a   Kim, Myeong Jin ^a   Ahn, Joong Bae ^a   Hur, Hyuk ^a   Lim, Joon Seok ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Jungwon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; IRINOTECAN; OXALIPLATIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; EXTRAMURAL VESSEL INVASION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INCIDENCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MESORECTAL FASCIA STATUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RECTUM CANCER; RECTUM RESECTION; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TUMOR INVASION; ANALYSIS OF VARIANCE; DRUG EFFECTS; KAPLAN MEIER METHOD; MIDDLE AGED; NEOADJUVANT THERAPY; PATHOLOGY; POSTOPERATIVE CARE; PROCEDURES; RADIATION RESPONSE; RECTAL NEOPLASMS; RECTUM; REMISSION; SURGERY; TUMOR RECURRENCE;

ADULT; AGED; ANALYSIS OF VARIANCE; CHEMORADIOTHERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; RECTAL NEOPLASMS; RECTUM; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84953897321     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146235     Document Type: Article

References (26)

1. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. The New England journal of medicine. 2004; 351:1731-40. PMID: 15496622
2. Park IJ, Yu CS. Current issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapy. World journal of gastroenterology: WJG. 2014; 20:2023-9. doi: 10.3748/wjg.v20.i8.2023 PMID: 24587677
3. Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. International journal of radiation oncology, biology, physics. 2005; 61:665-77.
4. Glynne-Jones R, Wallace M, Livingstone JI, Meyrick-Thomas J. Complete clinical response after preoperative chemoradiation in rectal cancer: is a 'wait and see' policy justified? Diseases of the colon and rectum. 2008; 51:10-9; discussion 9-20. PMID: 18043968
5. Santos MD, Silva C, Rocha A, Matos E, Nogueira C, Lopes C. Tumor regression grades: can they influence rectal cancer therapy decision tree? International journal of surgical oncology. 2013; 2013:572149. doi: 10.1155/2013/572149 PMID: 24187617
6. Mignanelli ED, de Campos-Lobato LF, Stocchi L, Lavery IC, Dietz DW. Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye? Diseases of the colon and rectum. 2010; 53:251-6. doi: 10.1007/DCR.0b013e3181bcd3cc PMID: 20173469
7. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr., Silva e Sousa AH Jr., et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: longterm results. Annals of surgery. 2004; 240:711-7; discussion 7-8. PMID: 15383798
8. Hur H, Kim NK, Min BS, Baik SH, Lee KY, Koom WS, et al. Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer? Diseases of the colon and rectum. 2014; 57:592-601. doi: 10.1097/DCR.0000000000000109 PMID: 24819099
9. Sohn B, Lim JS, Kim H, Myoung S, Choi J, Kim NK, et al. MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. European radiology. 2015; 25:1347-55. doi: 10.1007/s00330-014-3527-9 PMID: 25500963
10. Kim H, Lim JS, Choi JY, Park J, Chung YE, Kim MJ, et al. Rectal cancer: comparison of accuracy of local-regional staging with two- and three-dimensional preoperative 3-T MR imaging. Radiology. 2010; 254:485-92. doi: 10.1148/radiol.09090587 PMID: 20093520
11. Patel UB, Blomqvist LK, Taylor F, George C, Guthrie A, Bees N, et al. MRI after treatment of locally advanced rectal cancer: how to report tumor response-the MERCURY experience. AJR American journal of roentgenology. 2012; 199:W486-95. PMID: 22997398
12. Bernstein TE, Endreseth BH, Romundstad P, Wibe A, Norwegian Colorectal Cancer G. Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg. 2009; 96:1348-57. doi: 10.1002/bjs. 6739 PMID: 19847867
13. Oberholzer K, Junginger T, Heintz A, Kreft A, Hansen T, Lollert A, et al. Rectal Cancer: MR imaging of the mesorectal fascia and effect of chemoradiation on assessment of tumor involvement. Journal of magnetic resonance imaging: JMRI. 2012; 36:658-63. doi: 10.1002/jmri.23687 PMID: 22592948
14. Vliegen RF, Beets GL, Lammering G, Dresen RC, Rutten HJ, Kessels AG, et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology. 2008; 246:454-62. doi: 10.1148/radiol.2462070042 PMID: 18227541
15. Kim SH, Lee JM, Park HS, Eun HW, Han JK, Choi BI. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Journal of magnetic resonance imaging: JMRI. 2009; 29:1093-101. doi: 10.1002/jmri.21742 PMID: 19388124
16. Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. The British journal of surgery. 2008; 95:229-36. PMID: 17932879
17. Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? European journal of radiology. 2004; 52:78-83. PMID: 15380850
18. Maas M, Nelemans PJ, Valentini V, Das P, Rodel C, Kuo LJ, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. The Lancet Oncology. 2010; 11:835-44. doi: 10.1016/S1470-2045(10)70172-8 PMID: 20692872
19. Taylor FG, Quirke P, Heald RJ, Moran BJ, Blomqvist L, Swift IR, et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2014; 32:34-43.
20. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2008; 26:303-12.
21. Madbouly KM, Hussein AM, Abdelzaher E. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer. American journal of surgery. 2014; 208:332-41. doi: 10.1016/j.amjsurg.2013.10.023 PMID: 24581995
22. Chand M, Evans J, Swift RI, Tekkis PP, West NP, Stamp G, et al. The Prognostic Significance of Postchemoradiotherapy High-resolution MRI and Histopathology Detected Extramural Venous Invasion in Rectal Cancer. Annals of surgery. 2015; 261:473-9. doi: 10.1097/SLA.0000000000000848 PMID: 25243543
23. Mantke R, Schmidt U, Wolff S, Kube R, Lippert H. Incidence of synchronous liver metastases in patients with colorectal cancer in relationship to clinico-pathologic characteristics. Results of a German prospective multicentre observational study. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2012; 38:259-65.
24. Chiang JM, Hsieh PS, Chen JS, Tang R, You JF, Yeh CY. Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy. World journal of surgical oncology. 2014; 12:197. doi: 10.1186/1477-7819-12-197 PMID: 24980147
25. Williamson JS, Jones HG, Davies M, Evans MD, Hatcher O, Beynon J, et al. Outcomes in locally advanced rectal cancer with highly selective preoperative chemoradiotherapy. The British journal of surgery. 2014; 101:1290-8. doi: 10.1002/bjs.9570 PMID: 24924947
26. Hunter CJ, Garant A, Vuong T, Artho G, Lisbona R, Tekkis P, et al. Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment. Annals of surgical oncology. 2012; 19:1199-205. doi: 10.1245/s10434-011-2036-1 PMID: 21913017